Enriqueta Felip on the best way to target BRAF V600E and MET in NSCLC
Stephen Liu shared on X:
“Dr. Enriqueta Felip at CIOT24 discussing the best way to target BRAF V600E and MET in NSCLC.
While we do see these alterations in patients with a smoking history and responses to immunotherapy do occur, great targeted options available as 1L therapy.”
Source: Stephen Liu/X
Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.
As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.
Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.
